Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors

Completed · Phase 1

Conditions studied: Advanced or Metastatic Solid Tumors

In brief

The purpose of this study is to evaluate the safety and tolerability of NMS-1286937, a polo-like-kinase 1 inhibitor, in patients with advanced metastatic solid tumor.

Key facts

Study ID
NCT01014429
Run by
Nerviano Medical Sciences
People needed
21
Starts
2009-11-01
Last updated by the study team
2012-09-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.